Atlantic Lithium Regulatory News (ALL)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

1 December 2014

Allocate Software Plc ("Allocate" or "Company")

- Exercise of options

- Directorate changes

- Payment of final dividend

- Cancellation of listing

Exercise of options

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions today announces that 3,047,330 ordinary shares of £0.05 each in the capital of the Company ("New Ordinary Shares") have been issued and allotted pursuant to the exercise of certain share options under the (i) Enterprise Management Incentive Scheme; (ii) Unapproved Executive Share Option Scheme; (iii) 2010 Executive Share Option Scheme; (iv) 2010 Unapproved Share Option Scheme; (v) 2011 Long Term Retention Plan; and (vi) 2014 Bonus Option Scheme, which became exercisable in full as a result of the offer by Acorn Bidco Limited for the entire issued share capital of Allocate being declared unconditional as to acceptances on 27 November 2014.

Following the exercise of certain share options, 150,000, 233,333 and 133,333 New Ordinary Shares were issued to Ian Bowles, Allen Swann and Chris Gale respectively (or a member of their family as defined by the AIM Rules).

Application will be made to the London Stock Exchange for the 3,047,330 New Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected on 3 December 2014. The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares.

Immediately prior to Admission, the total number of ordinary shares in issue was 68,305,539. The total number of ordinary shares in issue following Admission will be 71,352,869. Accordingly, the figure of 71,352,869 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

Directorate changes

Following the Annual General Meeting ("AGM") held 27 November 2014, the Company confirms that Lynn Drummond, Non-Executive Director, has resigned from the Company with immediate effect having not offered herself for re-election at the AGM. Furthermore, following the announcement on 13 February 2014 that Chris Gale intended to resign as a director of the Company, Allocate confirms that his resignation took effect from 27 November 2014.

Payment of final dividend

Further to the approval of the final dividend at the AGM, and as previously announced on 2 September 2014, the Company confirms that the dividend of 1.45 pence per ordinary share for the year ended 31 May 2014 will be paid on 5 December 2014 to shareholders on the register on 14 November 2014.

Cancellation of listing

Further to the announcement released on 27 November regarding the cancellation of trading in Allocate's Ordinary Shares on AIM, the Company can confirm that the last day of dealings will be 30 December 2014.

About Allocate Software Plc:

Allocate is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

The experience and in-depth knowledge gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi-disciplinary groups, across diverse locations.

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.